NCT03639480View on ClinicalTrials.gov

Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia

PHASE3UnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

October 13, 2017

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
HypertensionHyperlipidemia
Interventions
DRUG

Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg

Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg

DRUG

Amlodipine 10mg+Valsartan 160mg

Amlodipine 10mg+Valsartan 160mg

DRUG

Valsartan 160mg+Atorvastatin 40mg

Valsartan 160mg+Atorvastatin 40mg

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY